CHMP Withholds Support for Drugs Aimed at Duchenne Muscular Dystrophy, ALS

The EU’s Committee for Medicinal Products for Human Use (CHMP) isn’t supporting two drugs intended to treat patients with amyotrophic lateral sclerosis (ALS) and Duchenne muscular — diseases that have also struggled to get approved treatments in the US.
Source: Drug Industry Daily